HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation

Area of Science:

• Molecular Biology
• Developmental Biology
• Biochemistry

Background:

• Heparin/heparan sulfate (Hp/HS) binding protein HIP, also known as ribosomal protein L29, has diverse biological functions.
• Abnormal expression of essential molecules like ribosomal proteins can impair embryonic development.
• High HIP/RPL29 levels are observed in proliferating chondrocytes, suggesting a role in cartilage development.

Purpose of the Study:

• To investigate the role of HIP/RPL29 in chondrogenesis and skeletal growth.
• To determine if HIP/RPL29 is essential for maintaining chondrocyte proliferation and normal skeletal patterning.
• To explore the function of HIP/RPL29 beyond its role in protein translation.

Main Methods:

• Demonstrated HIP/RPL29 down-regulation in terminally differentiated chondrocytes.
• Utilized a ribozyme-mediated knock-down approach in C3H/10T(1/2) cells to partially reduce HIP/RPL29 expression.
• Assessed the impact of reduced HIP/RPL29 on chondrocytic differentiation in vitro and in developing mouse embryos.

Main Results:

• HIP/RPL29 is down-regulated in terminally differentiated chondrocytes of the growth plate.
• Partial reduction of HIP/RPL29 expression accelerates the differentiation of multipotent cells into cartilage-like cells.
• HIP/RPL29 presence during early chondrogenesis is essential for normal skeletal growth and patterning.

Conclusions:

• HIP/RPL29 is a novel and important regulator of chondrocytic growth and differentiation.
• HIP/RPL29 expression is required to maintain chondrocyte proliferation and prevent skeletal shortening.
• Ribosomal proteins can act as key regulators of cell growth and differentiation.